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ABSTRACT
Background
Postulated epidemiological associations are subject to several biases. We evaluated whether
the Chinese literature on human genome epidemiology may offer insights on the operation of
selective reporting and language biases.
Methods and Findings
We targeted 13 gene-disease associations, each already assessed by meta-analyses, including
at least 15 non-Chinese studies. We searched the Chinese Journal Full-Text Database for
additional Chinese studies on the same topics. We identified 161 Chinese studies on 12 of these
gene-disease associations; only 20 were PubMed-indexed (seven English full-text). Many studies
(14–35 per topic) were available for six topics, covering diseases common in China. With one
exception, the first Chinese study appeared with a time lag (2–21 y) after the first non-Chinese
study on the topic. Chinese studies showed significantly more prominent genetic effects than
non-Chinese studies, and 48% were statistically significant per se, despite their smaller sample
size (median sample size 146 versus 268, p , 0.001). The largest genetic effects were often seen
in PubMed-indexed Chinese studies (65% statistically significant per se). Non-Chinese studies of
Asian-descent populations (27% significant per se) also tended to show somewhat more
prominent genetic effects than studies of non-Asian descent (17% significant per se).
Conclusion
Our data provide evidence for the interplay of selective reporting and language biases in
human genome epidemiology. These biases may not be limited to the Chinese literature and
point to the need for a global, transparent, comprehensive outlook in molecular population
genetics and epidemiologic studies in general.
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Research conducted in non-English-speaking countries
may be published either in English-language journals that
are usually indexed in major international bibliographic
databases or in domestic journals, many of which are not
indexed in international databases. There is some empirical
evidence that the decision to publish in international versus
domestic journals may be inﬂuenced by the nature of the
results: Signiﬁcant results may be published in international
journals, while nonsigniﬁcant results appear in the local
literature, resulting in language bias (the ‘‘tower of Babel’’
bias) [1,2]. The opposite phenomenon, a reverse tower of
Babel bias, nevertheless has also been described [3] in which
most of the locally produced and published literature is
spuriously statistically signiﬁcant. Moreover, other investiga-
tors have questioned whether the inclusion or not of non-
English studies makes any meaningful difference in the
overall picture of the evidence [4].
The available evidence on these biases stems from the
literature of randomized controlled trials. However, there are
other ﬁelds in which language biases may be particularly
important to appreciate. Genetics poses some special
challenges. There are millions of polymorphisms in the
human genome, and an exponentially increasing number of
studies are trying to associate genetic polymorphisms with
the risk of common diseases or treatment outcomes [5]. The
risk conferred by each one of these genetic markers is usually
small [5], with odds ratios between 1.1 and 1.4. Therefore,
selective publication of studies with different results may
potentially invalidate the overall picture about genetic risk
factors. Moreover, there is major debate on whether there are
differences in the strength of the genetic effects across people
of different ‘‘racial’’ descent [6–8]. Language-related biases
would tend to affect predominantly literature that refers to
populations of speciﬁc ‘‘racial’’ descent, thus affecting the
larger debate on ‘‘racial’’ descent differences.
The Chinese literature is a prominent example of possible
bias, because a plethora of domestic scientiﬁc journals are not
cataloged in international databases. China accounts for one-
ﬁfth of the world population, and this research is of major
importance not only for China, but also internationally. It has
been estimated that overall, for each internationally indexed
publication from China, there are 18 publications in local
nonindexed journals [9]. The consequences of potential
selective publication and language biases for human genome
epidemiology research and for biomedical research in
general are unknown. Here we aimed to evaluate the extent
to which genetic association studies are published in local
Chinese journals not indexed in PubMed. We tried to
understand whether the results of the Chinese literature
differs from the results of the non-Chinese literature and
what the implications would be for the total evidence on
postulated epidemiological associations and inherent biases.
Methods
Definitions
The primary comparison addressed the results of Chinese
versus non-Chinese studies. ‘‘Chinese studies’’ refers to
studies performed in the People’s Republic of China,
regardless of the language of publication. All of them have
been performed in people of Chinese descent. Chinese
studies are further classiﬁed according to whether they are
indexed in PubMed or not. ‘‘Non-Chinese studies’’ refers to
studies performed outside of China, regardless of the
language of publication and regardless of the ‘‘racial’’ descent
of the studied populations. Non-Chinese studies are further
classiﬁed according to whether they evaluated people of
Asian or non-Asian descent.
Database of Meta-Analyses of Gene-Disease Associations
We used published meta-analyses of gene-disease associa-
tions with binary outcomes and unrelated subjects. Whenever
a publication provided data on more than one ‘‘racial’’
descent group, these were split and counted as separate
studies. We started from a dataset of 55 meta-analyses
previously used in an evaluation of differences between small
and larger genetic association studies with binary outcomes
[10]. The exact search strategy and eligibility criteria for these
meta-analyses have been described previously [10,11]. For
each one of them, we updated searches until December 2004,
in order to identify more recent meta-analyses on exactly the
same topic and containing more studies. More comprehen-
sive meta-analyses replaced the older ones. Then we focused
only on meta-analyses in which at least 15 non-Chinese
studies were already available. We took this approach because
there is evidence that the early literature on gene-disease
associations often provides unreliable, inﬂated results [11,12].
Moreover, Chinese studies may not appear for at least a few
years after the appearance of the ﬁrst non-Chinese studies,
thus meta-analyses with few non-Chinese studies may not
have had any Chinese studies published yet. Meta-analyses
were selected regardless of whether or not they already
included any studies from China or individuals of Chinese
ethnic descent. None of these meta-analyses had access to
Chinese journals not indexed in PubMed, and all included
studies were PubMed-indexed.
Search for Additional Studies from the Chinese Literature
For each of the eligible meta-analyses, we searched the
national Chinese database of biomedical literature (last
search December 2004) for potentially additional gene-
disease association studies published in local Chinese journals
that would fulﬁll the eligibility criteria of the original meta-
analysis. The Chinese Journal Full-Text Database covers 8,000
journals since 1994, and it is accessible with username and
password via the Web site of Tsinghua University. We
excluded family-based studies, since they are based on linkage
analyses, and these have also been excluded from the original
meta-analyses as well.
The search strategy for each topic used the name of each
genetic marker (using the abbreviated name of the gene, the
expanded name of the gene, and the polymorphism) in
combination with terms pertaining to the disease and/or
outcome of interest. Retrieved abstracts and articles were
further screened for eligibility by the same native Chinese
investigator (ZP) who performed the literature search. When
in doubt, two other investigators (JPAI and JL), one of them
Chinese-speaking (JL), decided on the study’s eligibility.
Data Extraction
From each eligible Chinese study, we recorded the name of
the ﬁrst author, journal of publication, year of publication,
PLoS Medicine | www.plosmedicine.org December 2005 | Volume 2 | Issue 12 | e334 1310
Gene Epidemiology: Local Literature Biasethnic descent, and data on the 232 table for the association
(data necessary to derive the crude odds ratio and standard
error thereof for the probed association). For consistency, the
same genetic contrast was used as in the original meta-
analysis. We also recorded whether the study was also indexed
in PubMed.
We also examined, in each Chinese article, whether the
disease was deﬁned with speciﬁc criteria, whether any effort
was described to ensure that the controls were indeed disease-
free or otherwise appropriate, whether it was speciﬁed that
genotyping was performed blinded to the clinical status,
whether there was any mention that the disease-free controls
were tested for conformity to Hardy-Weinberg equilibrium,
whether any authors were involved from countries other than
China, and whether the article was published in an interna-
tional or national versus a local journal.
Data extraction was performed by a native Chinese
investigator (ZP). Key data were independently veriﬁed by a
second investigator (FKK) whenever tables in English were
available or from another Chinese-speaking investigator (JL)
otherwise. The few discrepancies were discussed and con-
sensus was reached with a third arbitrator.
Data Analysis
Descriptive statistics summarized the number of studies,
total sample size, number and percentage of studies with
statistically signiﬁcant results on their own, and year of
publication. Sample sizes were compared between groups of
studies with the Mann-Whitney U test and with median
regression adjusted for topic (bootstrap p-values). The
proportion of studies with statistically signiﬁcant results was
compared with the v
2 test.
For each meta-analysis and for each group of studies, we
estimated the summary odds ratio with inverse variance
random effects models, which allow for between-study
heterogeneity and incorporate it in the calculations [13].
We tested for between-study heterogeneity with the v
2-
distributed Q statistic (considered signiﬁcant at p , 0.10) [13],
and estimated its extent with the I
2 statistic. I
2 ranges between
0% and 100% and represents the proportion of between-
study variability that can be attributed to heterogeneity
rather than chance (considered large for values of 75% and
higher) [14]. Given the prominent differences in effect sizes
between different groups of studies, it was considered
inappropriate to obtain an overall summary effect including
all of them. Instead, we estimated whether the results of
different groups of studies differed between themselves
beyond chance. A standardized z-score statistic was employed,
as previously described [15].
For Chinese studies, for each study we estimated the
probability that it would have a formally statistically
signiﬁcant result at the a ¼ 0.05 level, conditional on the
sample size of its case and control groups, the genetic marker
frequency in the controls, and the summary genetic effect
seen across Chinese studies. This calculation was performed
as a regular power calculation for a case-control study. The
sum of these probabilities across Chinese studies (the
expected number of studies with statistically signiﬁcant
results) was then compared to the observed number of
statistically signiﬁcant ﬁndings using a v
2 test.
We also compared PubMed-indexed versus not PubMed-
indexed Chinese studies as to all the other study and quality
characteristics mentioned in the Data Extraction section
above.
Analyses were conducted in Intercooled Stata 8.2 (Stata
Corp., College Park, Texas, United States) using the metan
module. p-Values are two-tailed.
Results
Data on Chinese and Non-Chinese Studies
Thirteen published meta-analyses were found with at least
15 non-Chinese studies [16–26]. Data on any Chinese studies
could be retrieved for 12 of those, and these 12 topics are
considered from now on (for the association of DRD2 TaqIA
polymorphism with alcoholism [26], no Chinese study was
identiﬁed; Table 1). Overall, there were 161 eligible Chinese
studies, only 20 of which were indexed in PubMed. Of the 20
Chinese studies indexed in PubMed (two on ID1, two on ID2,
one on ID3, two on ID4, ﬁve on ID10, one on ID11, and seven
on ID12; Table 1), only six had already been included in the
published meta-analyses (one on ID11 and ﬁve on ID12),
while the others were more recent; only seven of the 20 were
published in full-text English journals. Of the 309 non-
Chinese studies already included in the published meta-
analyses, 44 pertained to populations of Asian descent (Japan,
n ¼ 25; Korea, n ¼ 7; Chinese people outside of China, n ¼ 5;
Taiwan, n¼4; Malaysia, n¼2; and Singapore n¼1), and 265 to
people of non-Asian descent (Figure 1).
For six topics we retrieved an extensive Chinese literature
from the Chinese database (14–35 studies for each), while for
the other topics the Chinese studies were sparse (four or
fewer studies per topic) (Table 1). Chinese data were typically
sparse if the disease was relatively uncommon in China
compared with other countries, e.g., bladder cancer (bladder
cancer is almost 10-fold less common in China than in
Europe or the United States) [27] and alcoholism (at least
until the early 1990s) [28]; or if the disease was not very
common globally (e.g., systemic lupus erythematosus and
schizophrenia). Chinese studies were plentiful if the disease
was common (e.g., cancer in general, lung cancer, coronary
heart disease, and diabetic nephropathy), with the exception
of the postulated association of the ITGB3 gene with coronary
artery disease, for which only one Chinese study was available.
With one exception, where the ﬁrst Chinese study was
published in the same year as the ﬁrst non-Chinese study, the
ﬁrst Chinese study always appeared with a considerable time
lag compared with the remaining world literature (2–21 y;
Table 1).
Study Sample Sizes
The sample size for Chinese studies was signiﬁcantly smaller
than for non-Chinese studies (p , 0.001 both by U test and
topic-adjusted median regression; Figure 1). Although non-
Chinese studies of non-Asian descent populations overall
seemed to be larger than studies on non-Chinese studies of
Asian descent populations (p , 0.001 by U test), the difference
was lost after adjusting for topic (p ¼ 0.72). Chinese studies
indexed or not indexed in PubMed did not differ in sample
size (p¼0.79 by U test, p¼0.55 by median regression; Figure 1).
Statistically Significant Results
Overall, 78 (48%) of the 161 Chinese studies had formally
statistically signiﬁcant results. There was some heterogeneity
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only 57 (18%) of 309 non-Chinese studies had signiﬁcant
results, despite the larger sample size, and the percentage
differed greatly across the 12 topics (exact p , 0.001). As
shown in Figure 1, the proportion of formally statistically
signiﬁcant studies differed between PubMed-indexed Chinese
studies, non-PubMed-indexed Chinese studies, non-Chinese
studies of Asian-descent populations, and non-Asian studies
(65%, 46%, 27%, and 17%, respectively; p , 0.001 by v
2).
None of the ﬁve studies on Chinese-descent people living
outside of China had statistically signiﬁcant results.
Changes in Study Sample Sizes and Significant Results
over Time
The sample size of Chinese studies increased over time
(Spearman correlation coefﬁcient for publication year and
sample size, 0.32, p , 0.001), while this was not seen for non-
Chinese studies (correlation coefﬁcient 0.00, p ¼ 0.95). As for
non-Chinese studies, the proportion of Chinese studies with
formally signiﬁcant results did not increase over time; if
anything, there was a trend towards decrease (47/89 [53%] in
1993–2000 versus 41/72 [43%] in 2001–2004; p ¼ 0.27).
Comparison of Genetic Effects
Table 2 summarizes the genetic effect sizes. As shown,
whenever there was a sizeable literature of Chinese studies, the
gene-disease association was always formally signiﬁcant in
both non-Chinese and Chinese studies, but Chinese studies
always showed a larger genetic effect than the non-Chinese
studies (Figure 1). In ﬁve of the six topics the observed
difference was even beyond chance (p , 0.05 on the z-score).
Even with limited data, Chinese studies suggested larger
estimates than non-Chinese studies also in the other three
topics where there was some overall evidence for the presence
of a gene-disease association; the genetic effect difference was
beyond chance in one of the three topics (Table 2).
PubMed-indexed Chinese studies were too few for formal
comparisons, but the available data suggested that they often
tended to provide extreme estimates of genetic effects (Figure
2). In three of the ﬁve topics where at least two such studies
were available, their summary estimate was the most extreme
observed compared with any other group of studies (non-
PubMed Chinese, non-Chinese Asian, and non-Chinese non-
Asian).
Non-Chinese studies of Asian descent populations were
available for eight topics. In seven of the eight cases, the
estimated genetic effect size was stronger in these Asian-
descent studies than in the non-Chinese non-Asian descent
studies (Table 3). The difference was beyond chance in two
topics (the associations of MTHFR C677T polymorphism with
coronary heart disease [ID10], and of GSTM1 gene deletion
Table 1. Eligible Meta-Analyses
ID Disease/Outcome Gene (Polymorphism) Genetic Contrast Studies (Total Sample) Studies with p , 0.05 (%) First Year Published
Chinese Non-Chinese Chinese Non-Chinese Chinese Non-Chinese
1 Myocardial infarction ACE (insertion/deletion) DD versus DI þ II 27 (4,514) 15 (18,664) 17 (63) 6 (40) 1996 1992
2 Ischemic heart disease ACE (insertion/deletion) DD versus DI þ II 35 (6,586) 17 (21,876) 20 (57) 4 (23) 1998 1994
3 Cancer HRAS/HRAS1 (rare alleles) Rare versus common alleles 23 (1,559) 24 (8,542) 7 (30) 8 (33) 1994 1985
4 Bladder cancer NAT2 (slow acetylation
alleles)
Slow/slow versus others 3 (417) 20 (5,836) 1 (33) 6 (30) 2000 1979
5 Diabetic nephropathy ACE (insertion/deletion) II versus ID þ DD 25 (3,857) 20 (5,393) 8 (32) 6 (30) 1997 1994
6 Coronary artery disease ITGB3 (L33P) A2A2 versus A1A2 þ A1A1 1 (152) 31 (17,315) 0 (0) 4 (13) 1999 1996
7 Bladder cancer GSTM1 (gene deletion) Null/null versus others 2 (400) 20 (5,795) 1 (50) 7 (35) 2002 1992
8 SLE nephritis FCGR2A (R131H) RR versus RH þ HH 1 (86) 24 (2,801) 0 (0) 2 (8) 2003 1995
9 SLE FCGR2A (R131H) RR versus RH þ HH 2 (261) 21 (4,708) 2 (100) 4 (19) 2000 1995
10 Coronary heart disease MTHFR (677C/T) TT versus CC 14 (1,778) 40 (23,922) 8 (57) 7 (18) 1998 1996
11 Schizophrenia DRD3 (Bal1) Ser/Ser þ Gly/Gly
versus Ser/Gly
4 (1,527) 39 (8,556) 0 (0) 1 (2) 1993 1993
12 Lung cancer GSTM1 (gene deletion) Null/null versus others 24 (5,909) 38 (16,119) 14 (58) 3 (6) 1997 1991
ACE, angiotensin converting enzyme; DRD2/DRD3, dopamine receptor D2/D3; FCGR2A, low-affinity receptor of the Fc domain of immunoglobulin G; GSTM1, glutathione S-transferase M1; HRAS, Harvey rat sarcoma viral oncogene homolog;
ITGB3, platelet glycoprotein receptor IIIa; MTHFR, methylenetetrahydrofolate reductase; SLE, systemic lupus erythematosus.
DOI: 10.1371/journal.pmed.0020334.t001
Figure 1. Categorization of the Examined Genetic Association Studies
IQR, interquartile range; N, sample size (as median and interquartile range); StatSig, statistically significant at the 0.05 level.
DOI: 10.1371/journal.pmed.0020334.g001
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different groups were available, the non-Chinese studies of
Asian-descent populations seemed to have effect sizes some-
where between the effect sizes of Chinese studies and non-
Asian studies (see Figure 1).
Expected versus Observed Significant Findings in Chinese
Studies
Power calculations based on asymptotic statistical testing
suggested that even if the large summary genetic effects
claimed by the Chinese studies were genuine, one would
expect 56.6 formally statistically signiﬁcant studies, substan-
tially fewer than the 78 observed in the database (p , 0.001).
Based on exact statistical testing, one would expect 61.1
signiﬁcant studies instead of the 81 observed (p ¼ 0.001).
Qualitative Comparison of Chinese Studies Indexed versus
Not Indexed in PubMed
PubMed-indexed Chinese studies did worse than Chinese
studies not indexed in PubMed in deﬁning disease with
speciﬁc criteria (17/20 [85%] versus 137/141 [97%], respec-
tively; exact p ¼ 0.042), and in ascertaining the eligibility of
controls (13/20 [65%] versus 129/141 [92%], respectively;
exact p ¼ 0.003). However, the only three Chinese studies
mentioning blinding of the genotyping personnel to disease
status were PubMed-indexed (exact p ¼ 0.002). There was no
difference in testing for violations of the Hardy-Weinberg law
in the controls (5/20 [20%] versus 38/141 [27%], respectively;
exact p ¼ 1.00). Only PubMed-indexed Chinese studies had
any representation of authors from countries other than
China (4/20 [20%] versus 0/141 [0%], respectively; exact p ,
0.001). As expected, almost all (19/20 [95%]) PubMed-indexed
Chinese studies were published in international or national
Chinese journals, while only 22 (16%) of the 141 studies not
indexed in PubMed were published in national journals.
Discussion
This empirical evaluation reveals a large Chinese literature
on human genome epidemiology that deserves more atten-
tion from the international community. The vast majority of
this literature does not reach PubMed. Chinese studies usually
appear with a time lag of several years after an epidemio-
logical association is ﬁrst postulated in the world literature,
but many such studies are published, especially when the
disease is perceived to be common in China. Chinese studies
typically suggest much stronger genetic effects than non-
Chinese studies, and this may be even more prominent for
the few studies that reach PubMed. Although Chinese studies
are smaller than non-Chinese studies and thus even more
underpowered [5], surprisingly half of them reach formal
statistical signiﬁcance for the evaluated gene-disease associ-
ation. This exaggeration is seen across very diverse topics.
The larger genetic effects in Chinese studies are unlikely to
reﬂect genuine heterogeneity in the effects of genetic risk
factors across various ‘‘racial’’ descent populations [8].
Heterogeneity due to ancestry should not have led always to
larger effect sizes in all probed gene-disease associations.
Therefore, the most likely explanation is publication bias
against ‘‘negative’’ results [29–32] or other selection biases in
the chase for statistically signiﬁcant ﬁndings [33]. This
explanation is further supported by our analysis of the
expected number of statistically signiﬁcant ﬁndings. Even if
the average genetic effects in the Chinese studies were indeed
as large as those observed, one would expect far fewer
Chinese studies to have reached formal statistical signiﬁcance
on their own, given their small sample sizes. The alternative
explanation that Chinese investigators may be targeting high-
risk populations with particularly strong genetic effects is
unlikely given these data.
Language may be a marker for other confounding
characteristics of these studies, or even of the whole research
and publication milieu. Moreover, even within the English-
language studies, strong biases may occasionally operate in
the conﬁrmation process. Cultural issues may also be involved
with unstated pressures to ﬁnd positive results for various
reasons in different settings around the globe. Various
compromises of research quality may ensue.
We focused on gene-disease associations for which a
considerable number of studies have been published in the
English language. It is possible that there could be a
Table 2. Genetic Effects in Chinese and Non-Chinese Studies
ID Random Effects Odds Ratio (95% CI) Discrepancy in Effect (p-Value) I
2 for Heterogeneity (%)
Chinese Non-Chinese Chinese Non-Chinese
1 2.21 (1.84–2.66)
a 1.28 (1.09–1.50)
a  4.42 (,0.01) 35 65
2 2.02 (1.66–2.47)
a 1.20 (1.06–1.36)
a  4.36 (,0.01) 60 54
3 7.66 (4.51–13.0) 1.84 (1.54–2.21)  4.99 (,0.01) 0 7
4 3.06 (0.95–9.87)
a 1.43 (1.20–1.71)
a  1.26 (0.21) 81 48
5 0.53 (0.41–0.69) 0.68 (0.55–0.84)
a 1.43 (0.15) 66 50
6 0.83 (0.02–44.4) 1.10 (0.99–1.21)
a 0.14 (0.89) NP 45
7 1.58 (1.02–2.43) 1.44 (1.25–1.67)  0.38 (0.70) 0 27
8 0.83 (0.34–2.03) 1.11 (0.88–1.41) 0.63 (0.53) NP 26
9 2.87 (1.50–5.50) 1.29 (1.10–1.52)  2.33 (0.02) 0 19
10 2.03 (1.44–2.86)
a 1.14 (1.01–1.30)
a  3.09 (,0.01) 59 50
11 0.95 (0.76–1.17) 1.11 (1.01–1.22) 1.33 (0.18) 0 8
12 1.63 (1.38–1.92)
a 1.14 (1.07–1.22)  3.54 (,0.01) 52 0
The ID numbers correspond to Table 1. The discrepancy between the Chinese and non-Chinese studies is expressed as a z-score and the corresponding p-value.
aSignificant between-study heterogeneity (p , 0.10 for the Q statistic)
CI, confidence interval; NP, not pertinent (only one study available).
DOI: 10.1371/journal.pmed.0020334.t002
PLoS Medicine | www.plosmedicine.org December 2005 | Volume 2 | Issue 12 | e334 1313
Gene Epidemiology: Local Literature Biasreluctance to submit and publish ‘‘negative’’ or inconclusive
results when a large body of English-language literature has
shown the presence of genetic effects. Also attempts to
conﬁrm multiply supported ﬁndings may be more likely to be
made, especially with limited resources. However, such
pressure for unilateral conﬁrmation destroys the independ-
ence and thus also the importance of conﬁrmation.
Our observation is reminiscent also of the randomized trial
literature on acupuncture, where studies from China, Russia,
Japan, Hong Kong, and Taiwan almost always yielded
statistically signiﬁcant results, in contrast to studies per-
formed in other countries [3]. A predilection for the
dissemination of statistically signiﬁcant results in some non-
English speaking countries has also been suspected in other
ﬁelds, such as lung cancer chemotherapy trials [34]. To our
knowledge, there has been no prior documentation of this
phenomenon in molecular medicine. Given the rapid pace of
production of information in molecular genetics and other
Figure 2. Meta-Analyses of Gene-Disease Associations in a Large Number of Both Non-Chinese and Chinese Studies
Each study is shown by its odds ratio and 95% confidence intervals (CIs). The box of the point estimate is proportional to the study weight. Also shown
are summary estimates by random effects calculations (diamonds). Summary estimates are obtained separately for Chinese studies indexed in PubMed
(red), Chinese studies not indexed in PubMed (pink), non-Chinese studies of Asian descent populations (green), and studies of persons of non-Asian
descent (blue). An odds ratio of 1 means no genetic effect, odds ratios larger than 1 mean genetic predisposition, and odds ratios less than 1 mean
genetic protection.
DOI: 10.1371/journal.pmed.0020334.g002
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in the appraisal of cutting-edge science and may jeopardize
the credibility of molecular discovery research.
We also found some evidence that superimposed language
bias [2] is also operating in this literature. Typically, the few
PubMed-indexed Chinese studies showed the most extreme
genetic effects, and two-thirds of them reached formally
statistically signiﬁcant results on their own, even though their
sample size was very small. Therefore, analyses limited to
PubMed-indexed studies may sometimes yield spurious
results, if the summary estimates are driven by these extreme
ﬁndings. PubMed-indexed Chinese studies had worse quality
ratings in case and control deﬁnitions and ascertainment
than Chinese studies not indexed in PubMed. Language bias
may not be limited to China, but may also be pertinent to
other Asian countries with considerable scientiﬁc produc-
tion, and beyond. We found that non-Chinese Asian studies
also tend consistently to show relatively larger genetic effects
than non-Asian studies, although data were too sparse to be
deﬁnitive. The relative extent of selective reporting, pub-
lication bias, and language bias is difﬁcult to disentangle here
and may vary across topics and across local literatures. It
would also be useful to analyze the local literatures for
Japanese and Korean studies, where a considerable number of
local journals also exist.
The Chinese literature is essential for the evaluation of
evidence on genetic risk factors. China is making rapid
scientiﬁc progress in this ﬁeld, as in many others. It is already
participating in the Human Genome project, and the South-
ern China National Genome Research Center established in
Shanghai in 2001 creates new frontiers for gene-disease
association studies. Evidence on population genetics, as well
as for any other ﬁeld pertinent to population health, is
extremely important to obtain for China from a global
perspective. Moreover, it is unlikely that biases are limited to
China, as we discussed above. Also, European and American
studies are not necessarily unbiased. There is strong evidence
that early-published European and American studies that
appeared in the most prestigious journals tended to have
inﬂated results [11,35,36].
Here we did not update further the existing non-Chinese
data from the published meta-analyses. Our investigation
focused on the Chinese literature, and we tried to focus on
meta-analyses with a large number of included studies that
should hopefully have reached a stable effect estimate.
Nevertheless, for at least two of the postulated associations
examined here (the associations of ACE with cardiac out-
comes), a very large study [37] conducted after the meta-
analysis found absolutely no effect, while the previous studies
had found modest, but statistically signiﬁcant, genetic effects.
Thus not only was the discrepancy against the Chinese studies
even larger than what was found in our analyses, but the
evidence from the earlier European-descent studies, in
particular the smaller ones [16], had also been biased.
Since most effect sizes in genetic epidemiology, and most
other molecular medicine ﬁelds, are small or modest, one
wonders whether many of the postulated associations are
generated from the interplay of various reporting and local
literature biases that leave no country immune. In some of
these postulated associations, the observed effect sizes may
simply be estimates of the prevailing bias [38].
One might argue that the inclusion of poor-quality
research may contaminate the better literature rather than
provide a more accurate, comprehensive picture. Large-scale
aggregate evidence may arrive at erroneous conclusions if
studies are automatically included without some critical
appraisal. However, it is unfair to judge the quality of
research on the basis of its regional origin. Chinese studies
may often be as good as or even better than many or most
studies from countries publishing routinely in the English
language [39–41]. Efforts to improve the quality of research
around the globe should run in parallel with enhanced access
to global research results.
Our ﬁndings have two broad implications. First, language
bias may be important to consider in meta-analyses of
observational studies in general, and its impact may be as
large as or larger than its impact on randomized evidence.
Second, human genome epidemiology in particular is a global
enterprise, and a critical and comprehensive global view is
important to decipher artifacts from true genetic effects.
Large studies are useful to validate postulated gene-disease
associations [12]. However, such studies are difﬁcult to
conduct, they are not completely immune from biases, and
their targets must be carefully selected given the plethora of
test hypotheses in molecular genetics [5,42]. Besides large
studies, registration of investigators and data collections is
Table 3. Comparison of Genetic Effects in Non-Chinese Studies of Asian-Descent Populations and Non-Asian-Descent Studies
ID Non-Chinese Asian
Studies (Total Sample)
Random Effects Odds Ratio (95% CI) I
2 for Heterogeneity (%)
Non-Chinese Asian Non-Asian Non-Chinese Asian Non-Asian
4 3 (503) 2.09 (1.13–3.85) 1.39 (1.15–1.67)
a 85 0
5 5 (762) 0.50 (0.34–0.74) 0.76 (0.60–0.95)
a 31 45
7 4 (1,232) 1.76 (1.34–2.32) 1.38 (1.16–1.63)
a 03 3
8 7 (709) 1.21 (0.70–2.08) 1.10 (0.84–1.44)
a 03 7
9 7 (1,339) 1.01 (0.70–1.46) 1.37 (1.13–1.67) 0 32
10 3 (2,002) 1.93 (1.43–2.60) 1.08 (0.95–1.22)
a 04 1
11 8 (1,862) 1.12 (0.93–1.35) 1.11 (0.99–1.24) 0 20
12 7 (2,484) 1.33 (1.13–1.56) 1.11 (1.03–1.19) 0 0
The ID numbers correspond to Table 1. For ID numbers 1, 2, 3, and 6, there were no non-Chinese studies of Asian descent populations.
aSignificant between-study heterogeneity (p , 0.10 for the Q statistic)
CI, confidence interval.
DOI: 10.1371/journal.pmed.0020334.t003
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Gene Epidemiology: Local Literature Biasuseful to consider [42,43]. In contrast to randomized trials
[44], study registration is impractical in molecular medicine,
since investigators would be reluctant to share their
hypotheses in public. However, if all investigators working
on the genetics of a speciﬁc disease were registered in a
common network, then it would be easier to trace additional
unpublished or non-indexed data. Common networks would
also, hopefully, help to improve the quality of research. Such
networks should aim for a global, inclusive outlook. The
Chinese research output, as well as the output of other non-
English-speaking countries, should be appropriately cap-
tured. Failure to maintain a global outlook may result in a
scientiﬁc literature that is driven by the opportunistic
dissemination of selected results.
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Background There are many different places that medical research can
be published. However, some research is never published, which leads to
so-called publication bias. One of the biggest divides is between English
and non-English research. Research done in non-English-speaking
countries can be published in English journals that are usually indexed
in major international databases, but more often is published in
domestic journals, many of which are not indexed in international
databases. This selective publication is called language bias. Scientists
have questioned what difference the inclusion or not of non-English
studies makes to the total evidence. Publication bias is of concern,
especially in genetics, which is a very fast-moving area of research.
Why Was This Study Done? China is a prominent example of a nation
with many domestic journals that are not indexed in the international
databases. This study looked at Chinese genetic association studies.
Understanding the quality and findings of genetics research in China,
home to one-fifth of the world’s population, is essential for the
evaluation of evidence on genetic risk factors. The authors hoped this
study would help understand more about selective reporting and
language biases.
What Did the Researchers Do and Find? They found that there were
many studies (14–35 per topic) for each of the topics they chose to
assess, which covered diseases common in China. Generally, Chinese
studies appeared a considerable time (two to 21 years) after the first
non-Chinese study on the topic. Chinese studies showed stronger
genetic effects than non-Chinese studies, despite in some cases having
smaller sample sizes. The largest genetic effects were often seen in
Chinese studies indexed in Western databases.
What Do These Findings Mean? It seems that there is a combination of
selective reporting of studies with interesting findings, and language
biases in human gene studies. The main reason most studies didn’t
appear in the international literature was probably a combination of
publication bias and superimposed language bias. It is important to note
that such biases are not limited to Chinese literature. Researchers should
consider language bias when doing analyses of groups of studies, and
efforts to improve the quality of research around the globe should run in
parallel with enhanced access to global research results.
Where Can I Get More Information Online? The Cochrane Collabo-
ration has a small section explaining the different types of publication
bias:
http://www.cochrane-net.org/openlearning/HTML/mod15–2.htm
BMJ has a presentation on publication bias by a BMJ editor:
http://bmj.bmjjournals.com/talks/publication_bias/index.htm
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